Zofran is a brand-name prescription drug that prevents nausea and vomiting in people undergoing chemotherapy, radiation therapy, or surgery. It is currently available as a generic drug only.
Zofran is an antiemetic or anti-nausea drug that contains the active ingredient ondansetron. It works as a 5-HT3 receptor antagonist that blocks the effects of a chemical called serotonin in the brain. Serotonin stimulates receptors in the chemoreceptor trigger zone, an area of the brain that controls nausea and vomiting. By blocking serotonin, ondansetron helps calm the brain’s nausea reflex.
Zofran is often taken as a tablet with or without food. However, the dosage of Zofran can vary depending on the cause of nausea. It’s important to follow the dosage instructions of your healthcare provider to ensure you use Zofran safely and effectively.
Continue reading to learn more about Zofran’s dosage and administration.
RELATED: What is Zofran? | Get Zofran discounts
Zofran is currently sold as a generic medication that comes as a regular tablet, orally disintegrating tablet (ODT), and oral solution. Brand-name dosage forms have been discontinued. In a clinical setting, generic Zofran is also available as an injectable solution given intravenously (IV) or intramuscularly (IM). An ondansetron soluble film was once marketed under the brand name Zuplenz, but this brand and format are no longer available.
Tablet: 4 mg, 8 mg, and 24 mg
Orally disintegrating tablet: 4 mg and 8 mg
Oral solution: 4 mg per 5 mL
Injectable solution: 2 mg per mL
Ondansetron is approved by the Food and Drug Administration (FDA) to prevent nausea and vomiting in people undergoing highly or moderately emetogenic (nausea-inducing) chemotherapy or radiation therapy. Ondansetron is also approved to prevent nausea or vomiting after surgery.
Standard dosage for adults: 8 to 24 mg given in a single dose before chemotherapy, radiation therapy, or before anesthesia and sometimes every eight to 12 hours for one to two days afterward
Maximum dosage for adults: 24 mg per day
Zofran dosage chart for adults | |
---|---|
Indication | Standard dosage |
Highly-emetogenic chemotherapy | Oral: Single 24-mg dose given 30 minutes before chemotherapy. |
IV: 0.15 mg/kg (150 mcg/kg) delivered IV over a 15-minute period, starting 30 minutes before chemotherapy. The dosage may be given two more times, with the following doses given 4 and 8 hours after the first dose. | |
Moderately-emetogenic chemotherapy | Oral: 8 mg given 30 minutes before chemotherapy. Then, 8 mg given 8 hours after the first dose. Then, 8 mg every 12 hours for 1-2 days following the completion of chemotherapy. |
IV: 0.15 mg/kg (150 mcg/kg) delivered IV over a 15-minute period, starting 30 minutes before chemotherapy. The dosage may be given two more times, with the following doses given 4 and 8 hours after the first dose. Maximum of 16 mg/dose. | |
Total body irradiation | Oral: 8 mg single dose given 1-2 hours before each dose of radiation each day |
Single high-dose radiation to the abdomen | Oral: 8 mg given 1-2 hours before radiation treatment. Then, 8 mg every 8 hours after the first dose for 1-2 days following radiation treatment |
Daily fractionated radiation to the abdomen | Oral: 8 mg given 1-2 hours before radiation treatment. Then, 8 mg every 8 hours after the first dose for every day that radiation treatment is given. |
Postoperative nausea or vomiting | Oral: 16 mg single oral dose given 1 hour before anesthesia |
IV/IM: 4 mg single dose given immediately before anesthesia or after surgery |
Dosage sources include Epocrates, DailyMed, and PDR
Chemotherapy commonly causes nausea and vomiting as side effects. The risk of nausea and vomiting varies depending on the medication, dosage, and treatment schedule. Chemotherapy medications may be categorized as high, moderate, low, or minimal risk when it comes to potential nausea and vomiting.
For example, highly emetogenic drugs are medications that have a high risk of causing nausea and vomiting, with more than 90% of cancer patients experiencing these side effects without preventive treatment. Examples include cisplatin, dacarbazine, and high-dose cyclophosphamide. A high dose of ondansetron is typically given 30 minutes before highly emetogenic chemotherapy.
Moderately emetogenic drugs are medications with a moderate risk of causing nausea and vomiting, with 30% to 90% of cancer patients experiencing these side effects without preventive treatment. Examples include carboplatin, doxorubicin, and oxaliplatin, among others. 8 mg of ondansetron is given before and 8 hours after moderately emetogenic chemotherapy, and then 8 mg is taken every 12 hours for up to two days after treatment.
Radiation treatment for cancer often causes nausea and vomiting as a side effect, especially if the radiation is focused on the brain, liver, or gastrointestinal tract. There are different types of radiotherapy, including internal, external, and systemic radiation. The total radiation dose is usually divided into smaller doses called fractions to reduce side effects.
The recommended dosage regimens can vary depending on the type of radiation and where it’s focused.
Radiotherapy (general): 8 mg orally three times daily
Total body irradiation: 8 mg one to two hours before each fraction of radiotherapy
Single high-dose abdominal radiation: 8 mg one to two hours before radiation treatment. Then, 8 mg every eight hours after the first dose for one to two days following treatment
Fractionated abdominal radiation: 8 mg one to two hours before radiation treatment. Then, 8 mg every eight hours after the first dose for every day that treatment is given
Postoperative nausea and vomiting (PONV) is a common side effect of anesthesia, generally affecting around 20% to 30% of people undergoing surgery. The risk of severe nausea and vomiting may be higher after certain procedures, such as abdominal surgery.
In susceptible patients, nausea and vomiting typically occur within the first 24 hours after surgery in the postanesthesia care unit. Nausea and vomiting after surgery can be uncomfortable and sometimes lead to a prolonged hospital stay. Ondansetron may be given before anesthesia to prevent PONV, depending on the person’s risk for nausea.
PONV in adults: 16 mg single dose given one hour before anesthesia
Ondansetron oral tablets can be given to prevent nausea and vomiting due to chemotherapy in children four years of age and older. In children and infants six months and older, ondansetron is given intravenously to prevent nausea and vomiting caused by chemotherapy.
For postoperative nausea and vomiting, IV ondansetron may be given to children and infants as young as one-month-old. However, the dosage varies depending on the individual’s weight. Ondansetron is typically given as a single IV dose immediately before or after surgery in children and infants to prevent postoperative nausea and vomiting.
Zofran dosage chart for children | |
---|---|
Indication | Standard dosage |
Moderately emetogenic chemotherapy in children ages 12-17 years old | Oral: Initial dose of 8 mg given 30 minutes before chemotherapy. Then, a subsequent 8-mg dose given eight hours later. Then, 8 mg every 12 hours for 1-2 days after completion of chemotherapy. |
Moderately emetogenic chemotherapy in children ages 4-11 years old | Oral: Initial dose of 4 mg given 30 minutes before chemotherapy. Then, 4 mg given four and eight hours after the first dose. Then 4 mg 3 times daily for 1-2 days after completion of chemotherapy. |
Emetogenic chemotherapy (any risk level) in children and infants 6 months and older | IV: 0.15 mg/kg per dose (maximum of 16 mg per dose) given over 15 minutes starting 30 minutes before chemotherapy. Dosage is repeated 4 and 8 hours after the first dose for a total of 3 doses per day. |
Postoperative nausea and vomiting in children and infants 1 month to 12 years and more than 40 kg (~88 lbs) | IV: 4 mg given immediately before anesthesia or shortly after surgery |
Postoperative nausea and vomiting in children and infants 1 month to 12 years and 40 kg (~88 lbs) or less | IV: 0.05 to 0.1 mg/kg given immediately before anesthesia or shortly after surgery |
Ondansetron is not right for everyone. The use of ondansetron should be avoided in people with a known allergy to any ingredients in the medication. Signs and symptoms of a serious allergic reaction may include hives, rash, swelling of the throat or face, and difficulty breathing.
Ondansetron should not be taken with Apokyn (apomorphine), a drug prescribed to treat Parkinson’s disease. Mixing these drugs can lead to low blood pressure (hypotension) and unconsciousness. Ondansetron may also interact with other medications, including serotonergic drugs and medications that affect liver metabolism.
Other warnings and precautions of ondansetron include:
Heart rhythm problems (QT interval prolongation and Torsades de Pointes), especially in people with electrolyte imbalances, heart failure, or other heart problems
Serotonin syndrome, is a potentially serious condition that may require treatment, especially in people who are taking serotonergic drugs
Ischemic heart disease or reduced blood flow to the heart muscle, leading to chest pain or tightness in the chest
Gastrointestinal problems
Phenylketonuria (PKU) due to the phenylalanine content of ondansetron ODT
Ondansetron is metabolized by the liver. Therefore, people with severe liver disease (severe hepatic impairment) may be restricted to a lower dose of 8 mg of ondansetron per day. People with kidney disease (renal impairment) generally do not require a dosage adjustment.
Ondansetron can be taken orally as a tablet, orally disintegrating tablet, or oral solution. It can be taken with or without food, and the effects should start within 30 minutes to an hour after oral administration.
The dosage will vary depending on a person’s overall condition and what the medication is being used for. IV and IM ondansetron will be administered in a hospital or clinical setting. Ondansetron should only be taken as directed by a doctor or healthcare provider.
Take oral tablets with a full glass of water
Store tablets at room temperature (36°F to 86°F) in a light-resistant container
Do not open the blister pack containing the tablet until you are ready to take it
Do not push the tablet through the foil backing to remove it
With dry hands, peel back the foil backing of one blister and gently remove the tablet
Place the tablet on the tongue. Allow the tablet to dissolve fully. It will dissolve in seconds
Swallow what’s left of the tablet with saliva
Store ondansetron orally disintegrating tablets at room temperature (36°F to 86°F)
Make sure to keep the bottles upright and store them between 59°F and 86°F
To protect the oral liquid form from light exposure, keep the bottles inside their cartons
Ondansetron generally starts working within 30 minutes to an hour. It reaches peak levels in the blood at around one and a half hours after taking oral administration. It may take a longer time for Zofran oral tablets to work than Zofran ODT or IV forms.
How long ondansetron stays in your system depends on various factors, including age and overall health. The half-life of an 8-mg tablet or IV dose of ondansetron is around three to four hours. However, in older adults with decreased liver function, the half-life may be around five and a half hours. As it takes four to five half-lives for a drug to be cleared from the body, ondansetron could stay in your system for up to 20 hours after a dose.
Ondansetron injectable solution is infused slowly to prevent the risk of side effects. Injecting the medication could increase the risk of side effects such as headache, dizziness, and skin flushing. The recommended time frame for administering a dose of ondansetron is typically over 15 minutes in adults and two to five minutes in pediatric patients.
If you miss a dose of ondansetron, take it as soon as you remember unless it's almost time for your next dose. In that case, skip the missed pill and continue your regular schedule. Do not take a double dose to make up for the missed one. If you're unsure what to do, consult your doctor or pharmacist for guidance on managing additional doses.
Yes, it is possible to overdose on ondansetron. An ondansetron overdose can be a serious medical emergency that can cause temporary vision loss, constipation, low blood pressure, and fainting. Children who overdose on Zofran are especially vulnerable to serotonin syndrome, a potentially dangerous condition that can cause drowsiness, rapid heart rate, increased sweating, and seizures. Seek immediate medical help if you suspect an overdose.
There are several possible drug interactions between ondansetron and other prescription medications. The concomitant use of other medicines with ondansetron could lead to severe adverse effects and may need to be avoided or monitored. For example, using serotonergic drugs, including SSRI antidepressants and certain migraine medications, may increase the risk of serotonin syndrome.
The use of ondansetron should be monitored while using drugs that can cause an irregular heartbeat as a side effect. For example, antiarrhythmics are drugs that may increase the risk of QT prolongation or an abnormal heart rhythm while taking Zofran.
Certain medications can affect the metabolism of ondansetron in the liver. Some drugs, such as certain antibiotics and antifungals, can cause ondansetron to build up, leading to an increased risk of serious side effects. Other medicines can cause ondansetron to break down, reducing its effectiveness.
Tell your healthcare provider if you take other medications, including prescription drugs, over-the-counter medicine, or herbal supplements.
Various studies have shown that the use of Zofran is not linked to abnormal pregnancy outcomes. However, a small number of studies have found that ondansetron may have a small risk of heart problems, including septum defects, in an unborn baby. It is important to consult a healthcare provider for more information and medical advice on treatment options for nausea during pregnancy.
Consensus guidelines for the management of postoperative nausea and vomiting, Anesthesia & Analgesia
Drug-induced QT prolongation, U.S. Pharmacist
Nausea and vomiting related to cancer, National Cancer Institute
Ondansetron drug summary, Prescriber’s Digital Reference
Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers, International Journal of Clinical Pharmacology and Therapeutics
Zofran, Epocrates
Zofran ondansetron 4 mg orally disintegrating tablet prescribing information, U.S. National Library of Medicine
Zofran ondansetron hydrochloride film-coated tablet prescribing information, U.S. National Library of Medicine
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...Health education, drug info, wellness & more
(Except Major Holidays)
© 2024 SingleCare Administrators. All Rights Reserved.
* Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
This is a prescription discount plan. This is NOT insurance nor a Medicare prescription drug plan. The range of prescription discounts provided under this discount plan will vary depending on the prescription and pharmacy where the prescription is purchased and can be up to 80% off the cash price. You are fully responsible for paying your prescriptions at the pharmacy at the time of service, but you will be entitled to receive a discount from the pharmacy in accordance with the specific pre-negotiated discounted rate schedule. Towers Administrators LLC (operating as 'SingleCare Administrators') is the authorized prescription discount plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services LLC ('SingleCare') is the vendor of the prescription discount plan, including their website.website at www.singlecare.com. For additional information, including an up-to-date list of pharmacies, or assistance with any problems related to this prescription drug discount plan, please contact customer service toll free at 844-234-3057, 24 hours a day, 7 days a week (except major holidays). By using the SingleCare prescription discount card or app, you agree to the SingleCare Terms and Conditions found at https://www.singlecare.com/terms-and-conditions